Litcius/Paper detail

Cannabis Cessation, Inflammatory Markers and Schizophrenia

Bruno Roméo, Valentine Lestra, Catherine Martelli, Amine Benyamina, Nora Hamdani

2022Journal of Dual Diagnosis11 citationsDOI

Abstract

In our study, cannabis cessation raises inflammatory markers though improving clinical symptoms. The investigation and the understanding of interactions between cannabis use and inflammatory markers in patients with schizophrenia is of importance and could in the future be a new target for treatment of psychiatric symptoms linked to inflammation.

Topics & Concepts

CannabisSchizophrenia (object-oriented programming)MedicineInternal medicineFibrinogenInflammationC-reactive proteinUrinary systemPsychosisPsychiatryGastroenterologyCannabis and Cannabinoid ResearchTryptophan and brain disordersSleep and related disorders
Cannabis Cessation, Inflammatory Markers and Schizophrenia | Litcius